FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Manufacturer

Country

Certificates

FDA

Document

No Title 0.6 MB
Registration Date 14 Oct 2016
Share

TAXOTERE®

(0)

Medicine Pharmaceuticals Product Number : 0075-8004-04

Antineoplastic Agent

Drug Information

Generic
Docetaxel
NDC Code
0075-8004-04
Drug Class
Mitotic inhibitors
Therapeutic Class
Antineoplastic Agent
Dosage form
Solution
Route of Administration
Intravenous Injection
Therapeutic Area
1.Carcinoma 2.Non-Small-Cell Lung Prostatic 3.Neoplasms Head and Neck Neoplasms 4.Stomach Neoplasms Adenocarcinoma 5.Breast Neoplasms

Nanomaterials

Manufacturer Asserted

Micelle

Nanocolloid,Nanocapsule

Indication

Docetaxel is an antineoplastic agent belonging to the taxoid family. It is prepared by semi-synthesis, starting with a precursor derived from renewable needle biomass of yew plants. Docetaxel (C43H53NO14) is a white to near-white powder with a molecular weight of 861.9 kDa. In water, it is strongly lipophilic and insoluble. Taxotere is recommended to treat patients with locally advanced or metastatic breast cancer when previous chemotherapy has failed.